视网膜纤维病变和潜在的基因疗法:关注人类iPSC衍生器官模型
Andrew McDonald1, Jan Wijnholds1,2
1Department of Ophthalmology, Leiden University Medical Center (LUMC), 2333 ZC Leiden, The Netherlands.
International journal of molecular sciences
|March 13, 2024
概括
来自干细胞的人类视网膜器官提供了一个有前途的模型来研究遗传性视网膜疾病,称为纤维病. 本综述探讨了它们在开发新基因疗法方面的潜力.
科学领域:
- 眼科和遗传学 眼科和遗传学
- 干细胞生物学和再生医学
背景情况:
- 光受体功能依赖于专门的毛;缺陷导致视网膜毛病,导致视力丧失.
- 动物模型往往无法完全复制人类视网膜纤维病变的表型.
- 人类诱导的多能干细胞 (hiPSCs) 为疾病建模提供了可行的替代方案.
研究的目的:
- 审查hiPSC衍生的3D视网膜器官对人类视网膜纤维病变的建模的实用性.
- 讨论视网膜纤维病的基因治疗策略,包括大基因传递和基因编辑.
主要方法:
- 利用人类诱导的多能干细胞 (hiPSCs) 来产生3D视网膜器官.
- 模拟与RPGR,CEP290,MYO7A和USH2A等基因相关的特定视网膜纤维病变.
- 审查当前和新兴的基因治疗方法来治疗这些疾病.
主要成果:
- 视网膜器官回顾了人类视网膜纤维病变的关键特征,包括光感受器纤维缺陷.
- 这些模型允许在特定的人类背景下研究疾病机制.
- 基因疗法的进步显示出治疗视网膜纤维病变的基因缺陷的潜力.
结论:
- 由hiPSC衍生的视网膜有机体代表了理解和治疗视网膜纤维病变的强大工具.
- 这项技术的进一步发展对于准确的疾病建模和治疗创新至关重要.
- 基因疗法在患有遗传性视网膜疾病的患者中恢复视力方面具有显著的前景.
关键词:
CEP29090 CEP29090 CEP29090 CEP29090 CEP29090 CEP29090 CEP29090 CEP29090 CEP290 CEP290 CEP290 CEP290 CEP290 CEP290 CEP290 CEP290 CEP290 CEP290 CEP290 CEP290 CEP290 CEP290 CEP290 CEP290 CEP290 CEP290 CEP290 CEP290这就是CRISPR/Cas9的作用.这就是MYO7A.这是一个RPGRPG.在USH2A中使用.腺相关病毒 (AAV)片 (cilium cilium) 是一种类型的细胞.基因治疗的基因疗法视网膜纤维病变 视网膜纤维病变视网膜的有机体更多相关视频
相关概念视频
iPS Cell Differentiation
2.7K
The ability of induced pluripotent stem cells or iPSCs to differentiate into most body cell types has stimulated repair and regenerative medicine research over the past few decades. iPSC-derived blood cells, hepatocytes, beta islet cells, cardiomyocytes, neurons, and other cell types can repair injuries or regenerate damaged tissue in diseases such as diabetes and neurodegenerative disorders.
2.7K
Induced Pluripotent Stem Cells
22.8K
Stem cells are undifferentiated cells that divide and produce different types of cells. Ordinarily, cells that have differentiated into a specific cell type are post-mitotic—that is, they no longer divide. However, scientists have found a way to reprogram these mature cells so that they “de-differentiate” and return to an unspecialized, proliferative state. These cells are also pluripotent like embryonic stem cells—able to produce all cell types—and are therefore...
22.8K
EPS and iPS Cells in Disease Research
2.8K
Embryonic and induced pluripotent stem cells are excellent models for disease research because of their ability to self-renew and differentiate into most cell types. Somatic cells from a patient are isolated and reprogrammed into induced pluripotent stem cells or iPSCs. These iPSCs are later differentiated into the desired cell type, which mirrors the diseased cell of the patient. In this way, disease models have been created for investigating diseases such as Down syndrome, type I diabetes,...
2.8K


